Table 1.
Datasets for human prostate cancer patients and cell lines
| Accession ID | PMID | Phenotype | Sample size |
|---|---|---|---|
| TCGA | Tumor | 384 | |
| SRP011439 | 21 804 560 | Benign vs localized tumor | 114 |
| SRP005908 | 21 036 922 | Prostate patients | 28 |
| GSE24283 | 21 261 984 | Tumor vs normal | 3/3 |
| SRP002628 | 21 571 633 | Tumors and adjacent normal tissues | 20/10 |
| ERP000550 | 22 349 460 | Tumor and adjacent normal tissues | 14/14 |
| SRP026387 | 24 054 872 | Pre and post treatment | 7/7 |
| GSE48812 | 25 044 704 | PrEC, LNCaP, PC3 | 12/12/12 |
| SRP013621 | 24 012 641 | Tumor | 1/1 |
| SRP027258 | 26 805 894 | PC3, LNCaP, PrEC | 12/12/12 |
| SRP010054 | 25 700 553 | LNCaP | 3/3 |
| SRP014759 | 25 274 489 | Tumor | 1/1 |
| GSE25183 | 21 804 560 | Normal vs tumor | 58 |